Ret Proto-Oncogene anticorps (AA 152-182)
Aperçu rapide pour Ret Proto-Oncogene anticorps (AA 152-182) (ABIN1930203)
Antigène
Voir toutes Ret Proto-Oncogene (RET) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 152-182
-
Marque
- IHC-plus™
-
Specificité
- This RET antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 152-182 amino acids from the N-terminal region of human RET.
-
Purification
- Ammonium sulfate precipitation
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Approved: IHC, IHC-P (5 μg/mL), WB (1:1000)
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, 0.09 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
-
Date de péremption
- 6 months
-
-
- Ret Proto-Oncogene (RET)
-
Autre désignation
- RET
-
Sujet
-
Name/Gene ID: RET
Subfamily: Cadherin
Family: Protein Kinase
Synonyms: RET, Cadherin family member 12, CDHF12, C-ret, Hirschsprung disease 1, HSCR1, Hydroxyaryl-protein kinase, Oncogene ret, Proto-oncogene c-Ret, RET-ELE1, RET51, Ret proto-oncogene, RET transforming sequence, RET43, Men2-ret, MEN2B, MTC1, Receptor tyrosine kinase, CDHR16, MEN2A, PTC, RET9 -
ID gène
- 5979
-
UniProt
- P07949
-
Pathways
- Signalisation RTK, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation
Antigène
-